Cargando…
Mechanistic Fingerprinting Reveals Kinetic Signatures of Resistance to Daptomycin and Host Defense Peptides in Streptococcus mitis-oralis
Streptococcus mitis-oralis (S. mitis-oralis) infections are increasingly prevalent in specific populations, including neutropenic cancer and endocarditis patients. S. mitis-oralis strains have a propensity to evolve rapid, high-level and durable resistance to daptomycin (DAP-R) in vitro and in vivo,...
Autores principales: | Yeaman, Michael R., Chan, Liana C., Mishra, Nagendra N., Bayer, Arnold S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068394/ https://www.ncbi.nlm.nih.gov/pubmed/33918000 http://dx.doi.org/10.3390/antibiotics10040404 |
Ejemplares similares
-
Metabolic changes associated with adaptive resistance to daptomycin in Streptococcus mitis-oralis
por: Parrett, Allison, et al.
Publicado: (2020) -
Strain-Specific Adaptations of Streptococcus mitis-oralis to Serial In Vitro Passage in Daptomycin (DAP): Genotypic and Phenotypic Characteristics
por: Mishra, Nagendra N., et al.
Publicado: (2020) -
1403. Daptomycin Combined with Low Dose Ceftriaxone Prevents the Emergence of Daptomycin Resistance against Streptococcus mitis-oralis Group in an In vitro Model of Simulated Endocardial Vegetations (SEVs)
por: Kebriaei, Razieh, et al.
Publicado: (2018) -
1703. Efficacy of Selected Metabolic Inhibitors for the Prevention and Resensitization of High-Level Daptomycin Resistance in Streptococcus mitis-oralis In Vitro and in an Ex Vivo Simulated Endocarditis Model
por: Kebriaei, Razieh, et al.
Publicado: (2022) -
614. Metabolic Interventions for the Resensitization of Daptomycin-Resistant (DAP-R) Streptococcus mitis-oralis Strains to DAP In vitro and Ex Vivo in a Simulated Model of Experimental Endocarditis (IE)
por: Somerville, Greg, et al.
Publicado: (2019)